Ensign Peak Advisors Inc decreased its position in shares of Chemed Co. (NYSE:CHE) by 7.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 14,656 shares of the company’s stock after selling 1,195 shares during the period. Ensign Peak Advisors Inc owned about 0.09% of Chemed worth $6,955,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also recently bought and sold shares of CHE. Northwestern Mutual Wealth Management Co. boosted its position in shares of Chemed by 1,700.0% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 54 shares of the company’s stock worth $26,000 after acquiring an additional 51 shares in the last quarter. Eagle Bay Advisors LLC acquired a new stake in shares of Chemed during the 2nd quarter worth approximately $64,000. Advisory Services Network LLC bought a new position in Chemed in the 2nd quarter valued at approximately $94,000. Jacobi Capital Management LLC lifted its stake in Chemed by 31.0% in the 2nd quarter. Jacobi Capital Management LLC now owns 203 shares of the company’s stock valued at $96,000 after purchasing an additional 48 shares during the last quarter. Finally, Sageworth Trust Co bought a new position in Chemed in the 1st quarter valued at approximately $100,000. Institutional investors and hedge funds own 87.51% of the company’s stock.
In related news, CEO Kevin J. Mcnamara sold 3,000 shares of Chemed stock in a transaction on Monday, August 9th. The shares were sold at an average price of $467.78, for a total transaction of $1,403,340.00. Following the completion of the transaction, the chief executive officer now owns 128,688 shares of the company’s stock, valued at $60,197,672.64. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 3.69% of the stock is owned by company insiders.
CHE stock opened at $408.46 on Thursday. The company has a fifty day moving average price of $461.56 and a 200-day moving average price of $472.57. The company has a market capitalization of $6.43 billion, a P/E ratio of 21.94, a PEG ratio of 3.52 and a beta of 0.45. Chemed Co. has a 52-week low of $403.00 and a 52-week high of $560.00.
Chemed (NYSE:CHE) last released its quarterly earnings results on Monday, July 26th. The company reported $4.60 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $4.29 by $0.31. The firm had revenue of $532.26 million during the quarter, compared to the consensus estimate of $511.85 million. Chemed had a net margin of 14.30% and a return on equity of 35.40%. The company’s revenue for the quarter was up 6.0% on a year-over-year basis. During the same quarter last year, the firm earned $4.41 earnings per share. As a group, sell-side analysts expect that Chemed Co. will post 17.9 earnings per share for the current year.
The company also recently announced a quarterly dividend, which was paid on Thursday, September 2nd. Investors of record on Monday, August 16th were paid a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a yield of 0.35%. The ex-dividend date of this dividend was Friday, August 13th. This is an increase from Chemed’s previous quarterly dividend of $0.34. Chemed’s dividend payout ratio (DPR) is currently 7.96%.
Chemed Corp. engages in the provision of healthcare and maintenance services. It operates through the VITAS and Roto-Rooter segments. The VITAS segment offers hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers.
Recommended Story: What is dividend yield?
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.